| __timestamp | Bio-Techne Corporation | CymaBay Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 15823000 |
| Thursday, January 1, 2015 | 40853000 | 17026000 |
| Friday, January 1, 2016 | 45187000 | 15941000 |
| Sunday, January 1, 2017 | 53514000 | 18938000 |
| Monday, January 1, 2018 | 55329000 | 58124000 |
| Tuesday, January 1, 2019 | 62413000 | 83837000 |
| Wednesday, January 1, 2020 | 65192000 | 35882000 |
| Friday, January 1, 2021 | 70603000 | 64542000 |
| Saturday, January 1, 2022 | 87140000 | 67995000 |
| Sunday, January 1, 2023 | 92493000 | 80118000 |
| Monday, January 1, 2024 | 96664000 |
Unlocking the unknown
In the ever-evolving world of biotechnology, innovation is the lifeblood that propels companies forward. Bio-Techne Corporation and CymaBay Therapeutics, Inc. are two such entities that have consistently invested in research and development (R&D) to stay ahead. Over the past decade, Bio-Techne has shown a steady increase in R&D spending, with a remarkable 212% growth from 2014 to 2023. In contrast, CymaBay's investment peaked in 2019, with a 430% increase from 2014, before experiencing fluctuations.
Bio-Techne's commitment to innovation is evident, with its R&D expenses reaching their highest in 2023, while CymaBay's data for 2024 remains elusive. This trend underscores the importance of sustained investment in R&D for long-term success in the biotech industry. As these companies continue to innovate, their contributions to healthcare advancements remain invaluable.
R&D Spending Showdown: AbbVie Inc. vs Bio-Techne Corporation
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Bio-Techne Corporation
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Bio-Techne Corporation
Dr. Reddy's Laboratories Limited or Bio-Techne Corporation: Who Invests More in Innovation?
Analyzing R&D Budgets: Bio-Techne Corporation vs Geron Corporation
Comparing Innovation Spending: Bio-Techne Corporation and Galapagos NV
Analyzing R&D Budgets: Bio-Techne Corporation vs Taro Pharmaceutical Industries Ltd.
Who Prioritizes Innovation? R&D Spending Compared for Madrigal Pharmaceuticals, Inc. and CymaBay Therapeutics, Inc.
R&D Spending Showdown: TG Therapeutics, Inc. vs CymaBay Therapeutics, Inc.
Research and Development Expenses Breakdown: CymaBay Therapeutics, Inc. vs Rhythm Pharmaceuticals, Inc.
CymaBay Therapeutics, Inc. vs Veracyte, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: CymaBay Therapeutics, Inc. vs Geron Corporation